By further including CD2 expression, the combination of absent HLA-DR, CD2 expression, and either absent CD11a or absent CD18 was identified in 92% of APL cases, with a specificity of 85% [58]. The gene discussed is ITGB2; the disease is acute promyelocytic leukemia.